• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-29b 调控人乳腺癌细胞的迁移。

miR-29b regulates migration of human breast cancer cells.

机构信息

School of Life Science, NJU 3 M Laboratory, Jiangsu Diabetes Research Center, Nanjing, Jiangsu, China.

出版信息

Mol Cell Biochem. 2011 Jun;352(1-2):197-207. doi: 10.1007/s11010-011-0755-z. Epub 2011 Feb 26.

DOI:10.1007/s11010-011-0755-z
PMID:21359530
Abstract

microRNAs (miRNAs) are short non-coding RNAs that regulate gene expression by targeting mRNAs, inhibiting the expression of the associated proteins. Although a role for aberrant miRNA expression in cancer has been postulated, the pathophysiologic role and relevance of aberrantly expressed miRNAs in tumor biology has not been established. We evaluated the expression pattern of miRNAs in human breast cancer cells by qPCR, finding out an up-regulated miRNA miR-29b and studying its biological effect by migration assay. We defined a target gene PTEN by bioinformatics approach and western blot. In breast cancer cell line MDA-MB-231 cell, which migrate faster than MCF-7, we observed that miR-29b was highly over-expressed. Inhibition of miR-29b in cultured cells increased the expression of the phosphatase and tensin homolog (PTEN) tumor suppressor, promoting apoptosis, decreasing migration, and decreasing invasion. In contrast, enhanced miR-29b expression by transfection with pre-miR-29b decreased the expression of PTEN and impaired apoptosis, increasing tumor cell migration and invasion. Moreover, PTEN was shown to be a direct target of miR-29b and was also shown to contribute to the miR-29b-mediated effects on cell invasion. Modulation of miR-29b altered the role of PTEN involved in cell migration and invasion. Aberrant expression of miR-29b, which modulates PTEN expression, can contribute to migration, invasion, and anti-apoptosis.

摘要

microRNAs (miRNAs) 是短的非编码 RNA,通过靶向 mRNAs 来调节基因表达,抑制相关蛋白质的表达。尽管已经提出了异常 miRNA 表达在癌症中的作用,但异常表达的 miRNAs 在肿瘤生物学中的病理生理作用和相关性尚未确定。我们通过 qPCR 评估了人乳腺癌细胞中 miRNAs 的表达模式,发现上调的 miRNA miR-29b,并通过迁移实验研究其生物学效应。我们通过生物信息学方法和 Western blot 定义了一个靶基因 PTEN。在 MDA-MB-231 细胞系中,该细胞系比 MCF-7 迁移更快,我们观察到 miR-29b 高度过表达。在培养细胞中抑制 miR-29b 会增加磷酸酶和张力蛋白同源物 (PTEN) 肿瘤抑制因子的表达,促进细胞凋亡,减少迁移和侵袭。相比之下,通过转染 pre-miR-29b 增强 miR-29b 的表达会降低 PTEN 的表达并损害细胞凋亡,增加肿瘤细胞的迁移和侵袭。此外,PTEN 被证明是 miR-29b 的直接靶标,并有助于 miR-29b 对细胞侵袭的调节作用。miR-29b 的调节改变了 PTEN 在细胞迁移和侵袭中所起的作用。miR-29b 的异常表达,调节了 PTEN 的表达,可以促进迁移、侵袭和抗凋亡。

相似文献

1
miR-29b regulates migration of human breast cancer cells.miR-29b 调控人乳腺癌细胞的迁移。
Mol Cell Biochem. 2011 Jun;352(1-2):197-207. doi: 10.1007/s11010-011-0755-z. Epub 2011 Feb 26.
2
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.微小RNA-21调节人类肝细胞癌中PTEN肿瘤抑制基因的表达。
Gastroenterology. 2007 Aug;133(2):647-58. doi: 10.1053/j.gastro.2007.05.022. Epub 2007 May 21.
3
MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN.微小RNA-29b通过靶向基质金属蛋白酶2和PTEN来减弱非小细胞肺癌的转移。
J Exp Clin Cancer Res. 2015 Jun 11;34(1):59. doi: 10.1186/s13046-015-0169-y.
4
A combined approach identifies three mRNAs that are down-regulated by microRNA-29b and promote invasion ability in the breast cancer cell line MCF-7.联合方法鉴定出三个受 microRNA-29b 下调的 mRNAs,这些 mRNAs 可促进乳腺癌细胞系 MCF-7 的侵袭能力。
J Cancer Res Clin Oncol. 2012 Dec;138(12):2127-36. doi: 10.1007/s00432-012-1288-x. Epub 2012 Aug 5.
5
miR-29b-3p promotes progression of MDA-MB-231 triple-negative breast cancer cells through downregulating TRAF3.miR-29b-3p 通过下调 TRAF3 促进 MDA-MB-231 三阴性乳腺癌细胞的进展。
Biol Res. 2019 Jul 26;52(1):38. doi: 10.1186/s40659-019-0245-4.
6
miR-29b suppresses proliferation, migration, and invasion of tongue squamous cell carcinoma through PTEN-AKT signaling pathway by targeting Sp1.微小RNA-29b通过靶向Sp1,经由PTEN-AKT信号通路抑制舌鳞状细胞癌的增殖、迁移和侵袭。
Oral Oncol. 2014 Nov;50(11):1062-71. doi: 10.1016/j.oraloncology.2014.07.010. Epub 2014 Aug 7.
7
MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.miR-222 和 miR-29a 有助于乳腺癌细胞的耐药性。
Gene. 2013 Nov 15;531(1):8-14. doi: 10.1016/j.gene.2013.08.062. Epub 2013 Aug 29.
8
EZH2-mediated Epigenetic Silencing of miR-29/miR-30 targets LOXL4 and contributes to Tumorigenesis, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer.EZH2 介导的 miR-29/miR-30 表达沉默靶向 LOXL4 并促进乳腺癌的发生、转移和免疫微环境重塑。
Theranostics. 2020 Jul 9;10(19):8494-8512. doi: 10.7150/thno.44849. eCollection 2020.
9
miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression.miR-142-3p 通过靶向 Bach-1 表达抑制人乳腺癌的致瘤性、侵袭和迁移,作为肿瘤抑制 miRNA。
J Cell Physiol. 2019 Jun;234(6):9816-9825. doi: 10.1002/jcp.27670. Epub 2018 Nov 27.
10
microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN.microRNA-21 通过靶向 PTEN 促进胃癌肿瘤的增殖和侵袭。
Oncol Rep. 2012 Apr;27(4):1019-26. doi: 10.3892/or.2012.1645. Epub 2012 Jan 19.

引用本文的文献

1
Regulatory Mechanisms of SPARC Overexpression in Melanoma Progression.SPARC过表达在黑色素瘤进展中的调控机制
Int J Mol Sci. 2025 Sep 8;26(17):8743. doi: 10.3390/ijms26178743.
2
Micro-RNAs in breast cancer progression and metastasis: A chromatin and metabolic perspective.从染色质和代谢角度看微小RNA在乳腺癌进展和转移中的作用
Heliyon. 2024 Sep 20;10(19):e38193. doi: 10.1016/j.heliyon.2024.e38193. eCollection 2024 Oct 15.
3
Vitamin D receptor polymorphisms and associated miRNAs in the development of breast cancer in African American women.

本文引用的文献

1
Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.miR-193b的下调有助于增强人乳腺癌中尿激酶型纤溶酶原激活剂(uPA)的表达以及肿瘤进展和侵袭。
Oncogene. 2009 Nov 5;28(44):3937-48. doi: 10.1038/onc.2009.245. Epub 2009 Aug 24.
2
3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma.3-磷酸肌醇依赖性激酶1增强乳腺癌中磷脂酰肌醇3-激酶途径的上游损伤。
Cancer Res. 2009 Aug 1;69(15):6299-306. doi: 10.1158/0008-5472.CAN-09-0820. Epub 2009 Jul 14.
3
维生素 D 受体多态性及其相关 microRNAs 在非裔美国女性乳腺癌发生中的作用。
Gene. 2024 Nov 15;927:148695. doi: 10.1016/j.gene.2024.148695. Epub 2024 Jun 28.
4
PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer.PI3K/AKT/mTOR 信号通路:三阴性乳腺癌的重要驱动因子和治疗靶点。
Breast Cancer. 2024 Jul;31(4):539-551. doi: 10.1007/s12282-024-01567-5. Epub 2024 Apr 17.
5
Unraveling the Potential of miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis.从 CSCs 中揭示 miRNA 的潜力,作为乳腺癌诊断和预后的新兴临床工具。
Int J Mol Sci. 2023 Nov 6;24(21):16010. doi: 10.3390/ijms242116010.
6
Expression of MiRNA-29b and MiRNA-31 and their diagnostic and prognostic values in Egyptian females with breast cancer.MiRNA - 29b和MiRNA - 31在埃及乳腺癌女性患者中的表达及其诊断和预后价值。
Noncoding RNA Res. 2022 Sep 6;7(4):248-257. doi: 10.1016/j.ncrna.2022.09.003. eCollection 2022 Dec.
7
Mir-29b in Breast Cancer: A Promising Target for Therapeutic Approaches.乳腺癌中的Mir-29b:一种有前景的治疗靶点
Diagnostics (Basel). 2022 Sep 2;12(9):2139. doi: 10.3390/diagnostics12092139.
8
Non-Exosomal and Exosome-Derived miRNAs as Promising Biomarkers in Canine Mammary Cancer.非外泌体和外泌体来源的微小RNA作为犬乳腺癌中有前景的生物标志物
Life (Basel). 2022 Apr 1;12(4):524. doi: 10.3390/life12040524.
9
LncRNA HOTAIR Promotes Chemoresistance by Facilitating Epithelial to Mesenchymal Transition through miR-29b/PTEN/PI3K Signaling in Cervical Cancer.长链非编码 RNA HOTAIR 通过 miR-29b/PTEN/PI3K 信号通路促进宫颈癌上皮间质转化从而增强化疗耐药性。
Cells Tissues Organs. 2022;211(1):16-29. doi: 10.1159/000519844. Epub 2021 Sep 27.
10
In silico model for miRNA-mediated regulatory network in cancer.癌症中 miRNA 介导的调控网络的计算模型。
Brief Bioinform. 2021 Nov 5;22(6). doi: 10.1093/bib/bbab264.
A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis.
一种具有多效性作用的微小RNA,即miR-31,可抑制乳腺癌转移。
Cell. 2009 Jun 12;137(6):1032-46. doi: 10.1016/j.cell.2009.03.047.
4
Simultaneous loss of the DLC1 and PTEN tumor suppressors enhances breast cancer cell migration.DLC1和PTEN肿瘤抑制因子的同时缺失会增强乳腺癌细胞的迁移能力。
Exp Cell Res. 2009 Sep 10;315(15):2505-14. doi: 10.1016/j.yexcr.2009.05.022. Epub 2009 May 29.
5
Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma.PI3K/Akt/PTEN信号通路失调是淋巴结阴性乳腺癌无病生存期短的一个标志物。
Hum Pathol. 2009 Oct;40(10):1408-17. doi: 10.1016/j.humpath.2009.02.005. Epub 2009 May 9.
6
MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells.微小RNA-21直接靶向MARCKS并促进前列腺癌细胞的抗凋亡和侵袭能力。
Biochem Biophys Res Commun. 2009 Jun 5;383(3):280-5. doi: 10.1016/j.bbrc.2009.03.077. Epub 2009 Mar 18.
7
MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo.miR-126 的恢复下调了 VEGF 的表达,抑制了肺癌细胞系在体外和体内的生长。
Lung Cancer. 2009 Nov;66(2):169-75. doi: 10.1016/j.lungcan.2009.01.010. Epub 2009 Feb 14.
8
MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.微小RNA表达及其对乳腺癌诊断和治疗策略的影响。
Cancer Treat Rev. 2009 Jun;35(4):328-34. doi: 10.1016/j.ctrv.2008.12.002. Epub 2009 Jan 25.
9
An investigation of microRNAs mapping to breast cancer related genomic gain and loss regions.一项针对定位于乳腺癌相关基因组扩增和缺失区域的微小RNA的研究。
Cancer Genet Cytogenet. 2009 Feb;189(1):15-23. doi: 10.1016/j.cancergencyto.2008.09.009.
10
MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer.微小RNA分析作为了解乳腺癌预后、治疗反应和耐药性的一种工具。
Eur J Cancer. 2008 Dec;44(18):2753-9. doi: 10.1016/j.ejca.2008.09.037. Epub 2008 Nov 18.